The newer generation of these medications, semaglutide (Ozempic and Rybelsus for T2D, Wegovy for weight reduction) and the dual GLP-1/ glucose-dependent insulinotropic polypeptide agonist ...

For those who prefer to avoid injections, there’s an oral form of semaglutide (Rybelsus) that’s approved ... “GLP-1 medications carry a black box warning for individuals with a history ...

Rybelsus (semaglutide) can cause side effects that range from mild to serious. More common side effects include constipation and diarrhea. If side effects from Rybelsus become difficult to ...

Rybelsus (semaglutide) is a prescription drug that’s used to manage blood sugar levels in people with type 2 diabetes. This drug can interact with other medications, such as levothyroxine ...

“Final Destination Bloodlines” is expected to rule the box office, trouncing fellow newcomer, the Weeknd’s roman à clef thriller “Hurry Up Tomorrow,” and ending the two-week reign of ...

The movie has gone onto become Sunny Paaji’s second highest-grossing film at the Indian box office. Let us take a look at the box office performance of the film on its 33rd day. However ...

Subscription boxes are a popular gift option, offering recurring deliveries of curated items. A wide variety of subscription boxes cater to diverse interests, from beauty and fashion to tech and food.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Sunny Deol's 'Jaat,' released in 2025 after the success of 'Gadar 2,' is struggling at the box office. Despite a weekend surge, the film experienced a significant drop on its third Monday ...

The company's experimental once-daily version will become the first oral GLP-1 for chronic weight management, if approved. U.S.-listed shares of Novo added to session gains and were last up 5.72% at ...